Member Info for Troutisout1

Despite the 1.5p quoted spread, they are still offering at 11.88p, which suggests they don't want new investors looking in for a bargain, with an advertised offer of 12.5p wildly above the real offer price.

The MMs can see the malaise and just drag the price down every day, sometimes they get sellers and other times buyers.

The fact that they don't leave the offer down for long suggests they haven't got endless sell orders as some suggest, the fact that there are regularly more buys than sells and the wide spreads just look like a fishing attempt. There are a couple of holders that have said they have been reducing their holding, it is probably just them actually selling.

This needs decent volumes to kick this out of this rut, but at the moment these aren't forthcoming. I do wonder how many PIs have invested in medical stocks before, they take an age to get to fruition and when they do they are usually snapped up by bigger fish. The jump is also vertical (if you are not in the day before the RNS release, you will not get in anywhere near that price at 8am on newsday).

DR5 could be a massive revenue opportunity for FAB, but it will take time to get there, same with OptiMAL. Patience is needed the wait doesn't mean it isn't happening, each week that goes by they are developing the assets and the pathway to contracts gets closer.

We also ignore some of the basic work they do, this is bringing in new bigger clients and better margin work. Get this approach right and the trust builds with these clients when it comes to future contracts (using OptiMAL, etc).

Https://gtr.ukri.org/projects?ref=10149702#/tabOverview

Not sure you can say a big seller? The volume has been dire this morning, bearing in mind the decent RNS.

A DR5 antibody is a huge potential product for someone willing to take it through to commercialisation, it will command a large price when licensed.

The fact that FAB are getting positive results on their development and they have got it so far already, is testament to their ability in developing successful antibodies. This could be huge and they know it...

Strangely you have just started it again, just leave it, stop trying to have the last word, silence is much better....Everyone had already done what you are asking, so stop it yourself....

Mmhater,

First, the £250k was in the FY2026 accounts but not in the cash figure. It will go into cash when we receive it.

Second, the placing raised £1.3m net we have no idea what was in the cashpot in January.

Third, they had £1.05m in cash at the end of March 2026, as we are only coming up to mid June, not sure where you get 4 months from?

Fourth, They had 21 staff and 3 NEDs as of the last Annual Report and the wage bill was £1.2m (£100k a month).

Fifth, You last comment might have said what you really mean, you seem to be a little angry rather than happy, if that is with me or the current silence, it will only get worse if you keep posting about it.

"Sorry to sound negative but getting annoyed with you he silence and happy to raise the points in the forum"

Sixth, there are large grant monies still to be taken in this current year from FMI and DR5 work and we were told that Gross margins rose from 22% to 43% in FY 2026.

Last, FAB is not the only stock that is slow at the moment, most are and the ones that you see shoot up, you probably wouldn't have invested in anyway, the grass is always greener doesn't always work.

But you all fan the flames by your responses, just filter and ignore.......

Mmhater, I can't see a need for a placing this year, let alone weeks away. They had over £1m end of March and have grant income from both FMI and DR5 work, as well as the £250k due from Finn. From what I can deduce they are getting business in and at better margin, H2 last year was much better than H1 and if that continues and all the other bits come in, they will be fine.

I get the need for Comms, but that is hard to deliver if their isn't the corresponding contract signings, etc, if they are going to say everything is going well but we still haven't signed anything yet, we will get a small spike and then the drift again. I have a holding in HVO which has had a poor time over the last 18 months, we knew they were waiting on client's to get funding before signing contracts and they have recently announced some good contracts and the price has risen (but not by as much as I expected). That had a large drift in SP as everyone waited for RNSs (not helped by ii's offloading some of their stock). This hasn't happened here and the support looks good (small persistent sells against larger buys when the price drops). It looks like our larger holders are sticking with it and I hope just like HVO, when the news starts to appear, more and more will be announced...

There has been 6m buys go through in the last 15 minutes....

Hi Prop,

I'm considerably richer than youuuu!

I loved those sketches by Harry Enfield, he was brilliant at watching people and turning that into comedy, it was funny as everyone knew that person/situation/environment.

As an old hand, I know you don't come over as that!

There are a few that are underwater and not happy with the SP movement, if only they could know what it was like many years ago and that some like you hung on and waited for this moment!

Just to confirm, the DR5 collaboration with QUB, is separate from the work on OptiMAL that the NCI are continuing and the only link is FAB and cancer.

NCI want to use OptiMAL and are continuing to use it while any longer term contract is being discussed. This acts as validation for the product.

The DR5 work could give FAB and QUB a licensable antibody that we would want Big Pharma to take on. This will be the money!

I have said before DR5 could be really big for Fusion and their shareholders...

Tebbin,

A rollover is where a holder sells some shares and then buys them back again at an extended settlement. The shares are sold and then bought back again, so no change in holding.

If it was a transfer, then again the holder sells and buys back in another account like an ISA, again no change in holding.

If it was a transfer between parties then one was the seller and the other the buyer.

It has all the elements of half a sell and half a buy, which most people usually discount, as they cancel each other out.

Actually it looks like someone bought £31k's worth having sold £30.9k's worth, rollover or transfer...

Investing is all about patience and keeping a sense of humour and perspective. I am lucky enough to have had quite a few shares from the basement levels but have added as the SP went up. It galls to see the SP drift, but shares drift for far longer periods than they rise, that is the nature of the beast.

However at 4.5p offered, I have just added another 250k...

NewOrmy,

Could you please cash out £50k's worth of SML stock, send it over to me and pretend the SP dropped and you lost it, I know it isn't everything but it is something...

LSInvestor,

Why do you mention Octopus as the seller twice in your post, but then say an institution is buying, it is Octopus buying, they are the same company that were selling and are now buying (in fact if you look back they bought some and then sold again, before buying more).

However the SP dropped on negative news regarding cancelled contracts and poor HCT take up (that is when the 2 II's started selling), that has changed with recent contracts and that is what the market will look on.

It was clear that someone was accumulating when the bid was being peppered but held steady, all good signs and great to have confirmation it was Octopus. Long way to go to get back to where it was, but I am optimistic it can do that and more in time....

Ii offering at 12.845p

Well just like last Tuesday, sitting here with more buys in the sell column than sells, the MMs want to keep the offer high as they don't want to attract more buyers with a 12.5p quoted offer, yet some are realising they are able to get that and buying anyway...

Did you not take any off the table at 28-30p levels?